Xanthinol nicotinate induced bullous drug eruption

Authors

  • Vandana Mehta
  • Vani Vasanth
  • C. Balachandran

DOI:

https://doi.org/10.66344/jpad.19.2.2009.526

References

Sean CS. In: Nutritional agents and vitamins. Martindale-The complete drug reference, 35th ed. Pharmaceutical press, London; 2007; Page1762-1836.

American society of Health-System Pharmacists. ASHP therapeutic position statement on the safe use of niacin in the management of dyslipidemias. Am J Health Syst Pharm 1997; 54: 2815-19.

Lavie CJ, Milani RV. Safety and side-effects of sustained release niacin. JAMA 1994; 272: 513-14.

Khan SA, Rodrigues G, Rao PGM. Nicotinic acid derivative induced bullous eruption. Int J Risk Safety Med 2006; 18: 159-62,

Downloads

Published

2016-12-24

How to Cite

1.
Mehta V, Vasanth V, Balachandran C. Xanthinol nicotinate induced bullous drug eruption. J Pak Assoc Dermatol [Internet]. 2016Dec.24 [cited 2026Apr.21];19(2):124-5. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/526

Issue

Vol. 19 No. 2 (2009): April - June

Section

Short Communications

License

Submission declaration

Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.

By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.

Most read articles by the same author(s)

1 2 > >>